These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28642587)

  • 21. The utility and limitation of single nucleotide polymorphism analysis on whole genome amplified mesenchymal tumour DNA in formalin fixed tumour samples.
    Liang CW; Lee YS; Marino-Enriquez A; Tsui K; Huang SH
    Pathology; 2012 Jan; 44(1):33-41. PubMed ID: 22157688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shallow whole genome sequencing for robust copy number profiling of formalin-fixed paraffin-embedded breast cancers.
    Chin SF; Santonja A; Grzelak M; Ahn S; Sammut SJ; Clifford H; Rueda OM; Pugh M; Goldgraben MA; Bardwell HA; Cho EY; Provenzano E; Rojo F; Alba E; Caldas C
    Exp Mol Pathol; 2018 Jun; 104(3):161-169. PubMed ID: 29608913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [High-throughput sequencing of frozen and paraffin-embedded tumor and normal tissue].
    Kerick M; Timmermann B; Schweiger MR
    Pathologe; 2010 Oct; 31 Suppl 2():255-7. PubMed ID: 20812012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded Tissue.
    Carrick DM; Mehaffey MG; Sachs MC; Altekruse S; Camalier C; Chuaqui R; Cozen W; Das B; Hernandez BY; Lih CJ; Lynch CF; Makhlouf H; McGregor P; McShane LM; Phillips Rohan J; Walsh WD; Williams PM; Gillanders EM; Mechanic LE; Schully SD
    PLoS One; 2015; 10(7):e0127353. PubMed ID: 26222067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precision oncology using a limited number of cells: optimization of whole genome amplification products for sequencing applications.
    Sho S; Court CM; Winograd P; Lee S; Hou S; Graeber TG; Tseng HR; Tomlinson JS
    BMC Cancer; 2017 Jul; 17(1):457. PubMed ID: 28666423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the quality of DNA from various formalin-fixed paraffin-embedded (FFPE) tissues and the use of this DNA for next-generation sequencing (NGS) with no artifactual mutation.
    Einaga N; Yoshida A; Noda H; Suemitsu M; Nakayama Y; Sakurada A; Kawaji Y; Yamaguchi H; Sasaki Y; Tokino T; Esumi M
    PLoS One; 2017; 12(5):e0176280. PubMed ID: 28498833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TargetPlex FFPE-Direct DNA Library Preparation Kit for SiRe NGS panel: an international performance evaluation study.
    Malapelle U; Pepe F; Pisapia P; Sgariglia R; Nacchio M; Barberis M; Bilh M; Bubendorf L; Büttner R; Cabibi D; Castiglia M; De Andrea CE; de Biase D; Dumur CI; Fontanini G; Freire J; Gristina V; Hofman P; Ilie M; Lozano MD; Merkelbach-Bruse S; Pappesch R; Pelusi N; Roma G; Russo A; Savic S; Siemanowski J; Tallini G; Tischler V; Vander Borght S; Weynand B; Xu T; Troncone G
    J Clin Pathol; 2022 Jun; 75(6):416-421. PubMed ID: 33766954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole-Transcriptome profiling of formalin-fixed, paraffin-embedded renal cell carcinoma by RNA-seq.
    Li P; Conley A; Zhang H; Kim HL
    BMC Genomics; 2014 Dec; 15(1):1087. PubMed ID: 25495041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes Project.
    Robbe P; Popitsch N; Knight SJL; Antoniou P; Becq J; He M; Kanapin A; Samsonova A; Vavoulis DV; Ross MT; Kingsbury Z; Cabes M; Ramos SDC; Page S; Dreau H; Ridout K; Jones LJ; Tuff-Lacey A; Henderson S; Mason J; Buffa FM; Verrill C; Maldonado-Perez D; Roxanis I; Collantes E; Browning L; Dhar S; Damato S; Davies S; Caulfield M; Bentley DR; Taylor JC; Turnbull C; Schuh A;
    Genet Med; 2018 Oct; 20(10):1196-1205. PubMed ID: 29388947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanding epigenomics to archived FFPE tissues: an evaluation of DNA repair methodologies.
    Siegel EM; Berglund AE; Riggs BM; Eschrich SA; Putney RM; Ajidahun AO; Coppola D; Shibata D
    Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2622-31. PubMed ID: 25472669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amplicon-Based Targeted Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Tissue.
    Strengman E; Barendrecht-Smouter FAS; de Voijs C; de Vree P; Nijman IJ; de Leng WWJ
    Methods Mol Biol; 2019; 1908():1-17. PubMed ID: 30649717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multi-institutional study to evaluate the feasibility of next-generation sequencing and genomic analysis using formalin-fixed, paraffin-embedded biopsies of gastric cancer.
    Kanda M; Terashima M; Kinoshita T; Yabusaki H; Tokunaga M; Kodera Y
    Gastric Cancer; 2023 Jan; 26(1):108-115. PubMed ID: 36369312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of quantitative PCR-based assays for detection of gene copy number aberrations in formalin-fixed, paraffin embedded solid tumor samples.
    Mehrotra M; Luthra R; Abraham R; Mishra BM; Virani S; Chen H; Routbort MJ; Patel KP; Medeiros LJ; Singh RR
    Cancer Genet; 2017 Apr; 212-213():24-31. PubMed ID: 28449808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reference Size Matching, Whole-Genome Amplification, and Fluorescent Labeling as a Method for Chromosomal Microarray Analysis of Clinically Actionable Copy Number Alterations in Formalin-Fixed, Paraffin-Embedded Tumor Tissue.
    Gunn SR; Govender S; Sims CL; Khurana A; Koo S; Scoggin J; Moore MW; Cotter PD
    J Mol Diagn; 2018 May; 20(3):279-288. PubMed ID: 29471114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formalin-fixed paraffin-embedded sample conditions for deep next generation sequencing.
    Nagahashi M; Shimada Y; Ichikawa H; Nakagawa S; Sato N; Kaneko K; Homma K; Kawasaki T; Kodama K; Lyle S; Takabe K; Wakai T
    J Surg Res; 2017 Dec; 220():125-132. PubMed ID: 29180174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients.
    Lee SH; Lee B; Shim JH; Lee KW; Yun JW; Kim SY; Kim TY; Kim YH; Ko YH; Chung HC; Yu CS; Lee J; Rha SY; Kim TW; Jung KH; Im SA; Moon HG; Cho S; Kang JH; Kim J; Kim SK; Ryu HS; Ha SY; Kim JI; Chung YJ; Kim C; Kim HL; Park WY; Noh DY; Park K
    Cancer Res Treat; 2019 Jan; 51(1):211-222. PubMed ID: 29690749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using postmortem formalin fixed paraffin-embedded tissues for molecular testing of sudden cardiac death: A cautionary tale of utility and limitations.
    Lin Y; Gryazeva T; Wang D; Zhou B; Um SY; Eng LS; Ruiter K; Rojas L; Williams N; Sampson BA; Tang Y
    Forensic Sci Int; 2020 Mar; 308():110177. PubMed ID: 32155531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exome enrichment and SOLiD sequencing of formalin fixed paraffin embedded (FFPE) prostate cancer tissue.
    Menon R; Deng M; Boehm D; Braun M; Fend F; Boehm D; Biskup S; Perner S
    Int J Mol Sci; 2012; 13(7):8933-8942. PubMed ID: 22942743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Genome Sequencing from Post-Mortem Formalin-Fixed, Paraffin-Embedded Lung Tissues.
    Van Campenhout C; De Mendonça R; Alexiou B; De Clercq S; Racu ML; Royer-Chardon C; Rusu S; Van Eycken M; Artesi M; Durkin K; Mardulyn P; Bours V; Decaestecker C; Remmelink M; Salmon I; D'Haene N
    J Mol Diagn; 2021 Sep; 23(9):1065-1077. PubMed ID: 34153515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heat-Induced Fragmentation and Adapter-Assisted Whole Genome Amplification Using GenomePlex® Single-Cell Whole Genome Amplification Kit (WGA4).
    El-Heliebi A; Chen S; Kroneis T
    Methods Mol Biol; 2015; 1347():101-9. PubMed ID: 26374312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.